世界のタイプAボツリヌス毒素市場予測（～2028年）：50U、100U、その他

• 英文タイトル：Global Type A Botulinum Toxin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8980 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

タイプAボツリヌス毒素市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のタイプAボツリヌス毒素の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 タイプAボツリヌス毒素市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・50U、100U、その他 用途別セグメントは次のように区分されます。 ・毒免疫、モノクローナル抗体 世界のタイプAボツリヌス毒素市場の主要な市場プレーヤーは以下のとおりです。 ・ALLERGAN、Roche、Pfizer、Galderma、Merz Pharma、DAEWOONG、Ipsen、Sinopharm 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、タイプAボツリヌス毒素製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なタイプAボツリヌス毒素メーカーの企業概要、2019年～2022年までのタイプAボツリヌス毒素の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なタイプAボツリヌス毒素メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別タイプAボツリヌス毒素の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのタイプAボツリヌス毒素の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのタイプAボツリヌス毒素市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびタイプAボツリヌス毒素の産業チェーンを掲載しています。 ・第13、14、15章では、タイプAボツリヌス毒素の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ALLERGAN、Roche、Pfizer、Galderma、Merz Pharma、DAEWOONG、Ipsen、Sinopharm ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：50U、100U、その他 ・用途別分析2017年-2028年：毒免疫、モノクローナル抗体 ・タイプAボツリヌス毒素の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・タイプAボツリヌス毒素のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・タイプAボツリヌス毒素のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・タイプAボツリヌス毒素の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・タイプAボツリヌス毒素の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Type A Botulinum Toxin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Type A Botulinum Toxin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Poison Immune accounting for % of the Type A Botulinum Toxin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 50U segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Type A Botulinum Toxin include ALLERGAN, Roche, Pfizer, Galderma, and Merz Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Type A Botulinum Toxin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50U
100U
Other
Market segment by Application can be divided into
Poison Immune
Monoclonal Antibody
The key market players for global Type A Botulinum Toxin market are listed below:
ALLERGAN
Roche
Pfizer
Galderma
Merz Pharma
DAEWOONG
Ipsen
Sinopharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Type A Botulinum Toxin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Type A Botulinum Toxin, with price, sales, revenue and global market share of Type A Botulinum Toxin from 2019 to 2022.
Chapter 3, the Type A Botulinum Toxin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Type A Botulinum Toxin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Type A Botulinum Toxin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Type A Botulinum Toxin.
Chapter 13, 14, and 15, to describe Type A Botulinum Toxin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Type A Botulinum Toxin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Type A Botulinum Toxin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 50U
1.2.3 100U
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Type A Botulinum Toxin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Poison Immune
1.3.3 Monoclonal Antibody
1.4 Global Type A Botulinum Toxin Market Size & Forecast
1.4.1 Global Type A Botulinum Toxin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Type A Botulinum Toxin Sales in Volume (2017-2028)
1.4.3 Global Type A Botulinum Toxin Price (2017-2028)
1.5 Global Type A Botulinum Toxin Production Capacity Analysis
1.5.1 Global Type A Botulinum Toxin Total Production Capacity (2017-2028)
1.5.2 Global Type A Botulinum Toxin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Type A Botulinum Toxin Market Drivers
1.6.2 Type A Botulinum Toxin Market Restraints
1.6.3 Type A Botulinum Toxin Trends Analysis
2 Manufacturers Profiles
2.1 ALLERGAN
2.1.1 ALLERGAN Details
2.1.2 ALLERGAN Major Business
2.1.3 ALLERGAN Type A Botulinum Toxin Product and Services
2.1.4 ALLERGAN Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Type A Botulinum Toxin Product and Services
2.2.4 Roche Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Type A Botulinum Toxin Product and Services
2.3.4 Pfizer Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business
2.4.3 Galderma Type A Botulinum Toxin Product and Services
2.4.4 Galderma Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merz Pharma
2.5.1 Merz Pharma Details
2.5.2 Merz Pharma Major Business
2.5.3 Merz Pharma Type A Botulinum Toxin Product and Services
2.5.4 Merz Pharma Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 DAEWOONG
2.6.1 DAEWOONG Details
2.6.2 DAEWOONG Major Business
2.6.3 DAEWOONG Type A Botulinum Toxin Product and Services
2.6.4 DAEWOONG Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ipsen
2.7.1 Ipsen Details
2.7.2 Ipsen Major Business
2.7.3 Ipsen Type A Botulinum Toxin Product and Services
2.7.4 Ipsen Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sinopharm
2.8.1 Sinopharm Details
2.8.2 Sinopharm Major Business
2.8.3 Sinopharm Type A Botulinum Toxin Product and Services
2.8.4 Sinopharm Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Type A Botulinum Toxin Breakdown Data by Manufacturer
3.1 Global Type A Botulinum Toxin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Type A Botulinum Toxin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Type A Botulinum Toxin
3.4 Market Concentration Rate
3.4.1 Top 3 Type A Botulinum Toxin Manufacturer Market Share in 2021
3.4.2 Top 6 Type A Botulinum Toxin Manufacturer Market Share in 2021
3.5 Global Type A Botulinum Toxin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Type A Botulinum Toxin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Type A Botulinum Toxin Market Size by Region
4.1.1 Global Type A Botulinum Toxin Sales in Volume by Region (2017-2028)
4.1.2 Global Type A Botulinum Toxin Revenue by Region (2017-2028)
4.2 North America Type A Botulinum Toxin Revenue (2017-2028)
4.3 Europe Type A Botulinum Toxin Revenue (2017-2028)
4.4 Asia-Pacific Type A Botulinum Toxin Revenue (2017-2028)
4.5 South America Type A Botulinum Toxin Revenue (2017-2028)
4.6 Middle East and Africa Type A Botulinum Toxin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Type A Botulinum Toxin Sales in Volume by Type (2017-2028)
5.2 Global Type A Botulinum Toxin Revenue by Type (2017-2028)
5.3 Global Type A Botulinum Toxin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Type A Botulinum Toxin Sales in Volume by Application (2017-2028)
6.2 Global Type A Botulinum Toxin Revenue by Application (2017-2028)
6.3 Global Type A Botulinum Toxin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Type A Botulinum Toxin Sales by Type (2017-2028)
7.2 North America Type A Botulinum Toxin Sales by Application (2017-2028)
7.3 North America Type A Botulinum Toxin Market Size by Country
7.3.1 North America Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
7.3.2 North America Type A Botulinum Toxin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Type A Botulinum Toxin Sales by Type (2017-2028)
8.2 Europe Type A Botulinum Toxin Sales by Application (2017-2028)
8.3 Europe Type A Botulinum Toxin Market Size by Country
8.3.1 Europe Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
8.3.2 Europe Type A Botulinum Toxin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Type A Botulinum Toxin Sales by Type (2017-2028)
9.2 Asia-Pacific Type A Botulinum Toxin Sales by Application (2017-2028)
9.3 Asia-Pacific Type A Botulinum Toxin Market Size by Region
9.3.1 Asia-Pacific Type A Botulinum Toxin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Type A Botulinum Toxin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Type A Botulinum Toxin Sales by Type (2017-2028)
10.2 South America Type A Botulinum Toxin Sales by Application (2017-2028)
10.3 South America Type A Botulinum Toxin Market Size by Country
10.3.1 South America Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
10.3.2 South America Type A Botulinum Toxin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Type A Botulinum Toxin Sales by Type (2017-2028)
11.2 Middle East & Africa Type A Botulinum Toxin Sales by Application (2017-2028)
11.3 Middle East & Africa Type A Botulinum Toxin Market Size by Country
11.3.1 Middle East & Africa Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Type A Botulinum Toxin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Type A Botulinum Toxin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Type A Botulinum Toxin
12.3 Type A Botulinum Toxin Production Process
12.4 Type A Botulinum Toxin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Type A Botulinum Toxin Typical Distributors
13.3 Type A Botulinum Toxin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---